Ruxolitinib and vedolizumab salvage therapy in the setting of cytomegalovirus colitis for a patient with newly diagnosed very early onset inflammatory bowel disease.
Saved in:
| Title: | Ruxolitinib and vedolizumab salvage therapy in the setting of cytomegalovirus colitis for a patient with newly diagnosed very early onset inflammatory bowel disease. |
|---|---|
| Authors: | Laxer A; Division of Pediatric Gastroenterology Cohen Children's Medical Center New Hyde Park New York USA., Edelman M; Division of Pediatric Pathology Cohen Children's Medical Center New Hyde Park New York USA., Gallagher J; Division of Pediatric Gastroenterology Cohen Children's Medical Center New Hyde Park New York USA., Sahn B; Division of Pediatric Gastroenterology Cohen Children's Medical Center New Hyde Park New York USA. |
| Source: | JPGN reports [JPGN Rep] 2025 Oct 30; Vol. 7 (1), pp. 114-117. Date of Electronic Publication: 2025 Oct 30 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101773885 Publication Model: eCollection Cited Medium: Internet ISSN: 2691-171X (Electronic) Linking ISSN: 2691171X NLM ISO Abbreviation: JPGN Rep Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2691-171X |
|---|---|
| DOI: | 10.1002/jpr3.70106 |
